Functionalized
Terpolymer-Brush-Based Biointerface
with Improved Antifouling Properties for Ultra-Sensitive Direct Detection
of Virus in Crude Clinical Samples
posted on 2021-12-13, 23:29authored byMichala Forinová, Alina Pilipenco, Ivana Víšová, N. Scott Lynn, Jakub Dostálek, Hana Mašková, Václav Hönig, Martin Palus, Martin Selinger, Pavlína Kočová, Filip Dyčka, Jan Štěrba, Milan Houska, Markéta Vrabcová, Petr Horák, Judita Anthi, Chao-Ping Tung, Chung-Ming Yu, Chi-Yung Chen, Yu-Chuan Huang, Pei-Hsun Tsai, Szu-Yu Lin, Hung-Ju Hsu, An-Suei Yang, Alexandr Dejneka, Hana Vaisocherová-Lísalová
New analytical techniques that overcome
major drawbacks of current
routinely used viral infection diagnosis methods, i.e., the long analysis
time and laboriousness of real-time reverse-transcription polymerase
chain reaction (qRT-PCR) and the insufficient sensitivity of “antigen
tests”, are urgently needed in the context of SARS-CoV-2 and
other highly contagious viruses. Here, we report on an antifouling
terpolymer-brush biointerface that enables the rapid and sensitive
detection of SARS-CoV-2 in untreated clinical samples. The developed
biointerface carries a tailored composition of zwitterionic and non-ionic
moieties and allows for the significant improvement of antifouling
capabilities when postmodified with biorecognition elements and exposed
to complex media. When deployed on a surface of piezoelectric sensor
and postmodified with human-cell-expressed antibodies specific to
the nucleocapsid (N) protein of SARS-CoV-2, it made possible the quantitative
analysis of untreated samples by a direct detection assay format without
the need of additional amplification steps. Natively occurring N-protein–vRNA
complexes, usually disrupted during the sample pre-treatment steps,
were detected in the untreated clinical samples. This biosensor design
improved the bioassay sensitivity to a clinically relevant limit of
detection of 1.3 × 104 PFU/mL within a detection time
of only 20 min. The high specificity toward N-protein-vRNA complexes
was validated both by mass spectrometry and qRT-PCR. The performance
characteristics were confirmed by qRT-PCR through a comparative study
using a set of clinical nasopharyngeal swab samples. We further demonstrate
the extraordinary fouling resistance of this biointerface through
exposure to other commonly used crude biological samples (including
blood plasma, oropharyngeal, stool, and nasopharyngeal swabs), measured
via both the surface plasmon resonance and piezoelectric measurements,
which highlights the potential to serve as a generic platform for
a wide range of biosensing applications.